The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 150,959 |
| Interest income on trust account | 645,454 |
| Change on fair value of over-allotment option liability | 87,000 |
| Share based compensation expense | 329,000 |
| Prepaid expenses | 137,474 |
| Accounts payable | 41,399 |
| Accrued expenses | 76,500 |
| Net cash used in operating activities | -272,070 |
| Investment in trust account | 220,000,000 |
| Net cash used in investing activities | -220,000,000 |
| Proceeds from sale of units | 220,000,000 |
| Proceeds from sale of private placement units | 7,700,000 |
| Payment of underwriter fees and commissions | 4,525,000 |
| Proceeds from issuance of class b ordinary shares | 25,000 |
| Proceeds from promissory note related party | 149,000 |
| Payment of promissory note related party | 149,000 |
| Payment of offering costs | 290,452 |
| Net cash provided by financing activities | 222,909,548 |
| Net change in cash and cash equivalents | 2,637,478 |
| Cash and cash equivalents end of period | 2,637,478 |